Резюме
Определение
Анамнез и осмотр
Ключевые диагностические факторы
- hematuria
- edema
- hypertension
Другие диагностические факторы
- oliguria
- anorexia
- nausea
- malaise
- weight loss
- fever
- skin rash
- arthralgia
- hemoptysis
- abdominal pain
- sore throat
- hypervolemia
Факторы риска
- group A beta-hemolytic Streptococcus
- respiratory infections
- gastrointestinal infections
- hepatitis B
- hepatitis C
- infective endocarditis
- HIV
- systemic lupus erythematosus (SLE)
- systemic vasculitis
- lung cancer
- colorectal cancer
- Hodgkin lymphoma
- non-Hodgkin lymphoma
- leukemia
- thymoma
- hemolytic uremic syndrome
- drugs
Диагностические исследования
Исследования, которые показаны в первую очередь
- urinalysis and microscopy of urine sediment
- comprehensive metabolic profile
- estimated glomerular filtration rate (eGFR)
- complete blood count
- lipid profile
- 24-hour urine collection
- ultrasound of kidneys
Исследования, проведение которых нужно рассмотреть
- spot urine protein:creatinine ratio (PCR)
- spot urine albumin:creatinine ratio (ACR)
- erythrocyte sedimentation rate (ESR) or C-reactive protein (CRP)
- complement levels
- rheumatoid factor
- antineutrophil cytoplasmic antibody
- antiglomerular basement membrane (GBM) antibody
- antistreptolysin O antibody
- antihyaluronidase
- anti-DNase
- anti-double-stranded DNA
- antinuclear antibody
- cryoglobulins
- hepatitis C virus and hepatitis B virus serology
- HIV serology
- serum or urine protein electrophoresis
- serum free light chains
- drug screen
- kidney biopsy
- antiphospholipase A2 receptor antibodies
- computed tomographic scan of chest and abdomen
Алгоритм лечения
mild disease
moderate-severe disease
rapidly progressive
Составители
Авторы
Nabeel Aslam, MD, FASN
Associate Professor of Medicine
Consultant Nephrologist
Mayo Clinic
Jacksonville
FL
Раскрытие информации
NA declares that he has served on advisory boards for Travere Therapeutics and Chinook Therapeutics. He has received research grants from Idorsia, Novartis, and Baxter.
Выражение благодарностей
Dr Nabeel Aslam would like to gratefully acknowledge Dr Jeremy Levy, Dr Padmanabhan Premkumar, Dr Priyanka Sharma, and Dr Ajay Kumar, previous contributors to this topic.
Раскрытие информации
JL, PP, PS, and AK declare that they have no competing interests.
Рецензенты
Martin Schreiber, MD
Department Chairman
Nephrology and Hypertension
Cleveland Clinic Foundation
Cleveland
OH
Disclosures
MS declares that he has no competing interests.
Patrick Naish, MB, FRCP
Teaching Fellow
Keele University Medical School
Keele
UK
Disclosures
PN declares that he has no competing interests.
Richard Banks, MBBS, FRCP, MD
Consultant Nephrologist
Gloucestershire Royal Hospital
Gloucester
UK
Disclosures
RB declares that he has no competing interests.
Mark Thomas, BSc, MBBS, MD, FRCP
Consultant Nephrologist
University Hospitals Birmingham
Birmingham
UK
Раскрытие информации
MT declares that he has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
Список литературы
Основные статьи
Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 Clinical practice guideline for the management of glomerular diseases. Kidney Int. 2021 Oct;100(4s):S1-276.Полный текст Аннотация
Sethi S, De Vriese AS, Fervenza FC. Acute glomerulonephritis. Lancet. 2022 Apr 23;399(10335):1646-63. Аннотация
Walters GD, Willis NS, Cooper TE, et al. Interventions for renal vasculitis in adults. Cochrane Database Syst Rev. 2020 Jan 13;(1):CD003232.Полный текст Аннотация
Статьи, указанные как источники
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
Отличия
- Nephrolithiasis
- Bladder cancer
- Renal cancer
Больше ОтличияDiretrizes
- KDIGO clinical practice guideline for antineutrophilic cytoplasmic antibody (ANCA)-associated vasculitis
- KDIGO clinical practice guideline for the management of lupus nephritis
Больше DiretrizesFolhetos informativos para os pacientes
Glomerulonephritis
Kidney infection
Mais Folhetos informativos para os pacientesCalculadoras
Glomerular Filtration Rate Estimate by CKD-EPI Equation
Mais CalculadorasConectar-se ou assinar para acessar todo o BMJ Best Practice
O uso deste conteúdo está sujeito ao nosso aviso legal